If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Dae Sik Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Peripheral T-Cell Lymphoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Survival Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 63 Citations
  • 5 h-Index
  • 15 Article
  • 2 Letter
  • 1 Comment/debate

Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma

Park, Y., Kim, D. S., Jeon, M. J., Lee, B. H., Yu, E. S., Kang, K. W., Lee, S. R., Sung, H. J., Nam, M-H., Yoon, S-Y., Choi, C. W., Kang, E. S., Cho, D., Kim, K., Kim, B. S., Kim, D. W. & Kim, S. J., 2019 Jan 1, In : Journal of Clinical Apheresis.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Etoposide
Multiple Myeloma
Stem Cell Transplantation
Blood Component Removal
1 Citation (Scopus)

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

Yhim, H. Y., Park, Y., Han, Y. H., Kim, S., Kang, S. R., Moon, J. H., Jeong, J. H., Shin, H. J., Kim, K., Choi, Y. S., Kim, K., Kim, M. K., Kong, E., Kim, D. S., Eo, J. S., Lee, J. H., Kang, D. Y., Lee, W. S., Lee, S. M., Do, Y. R. & 6 others, Ham, J. S., Kim, S. J., Kim, W. S., Choi, J. Y., Yang, D. H. & Kwak, J. Y., 2018 Dec 1, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2274-2284 11 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Neoplasms
Treatment Failure
Disease-Free Survival
Survival

Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score (European Journal of Nuclear Medicine and Molecular Imaging, (2018), 45, 13, (2274-2284), 10.1007/s00259-018-4093-1)

Yhim, H. Y., Park, Y., Han, Y. H., Kim, S., Kang, S. R., Moon, J. H., Jeong, J. H., Shin, H. J., Kim, K., Choi, Y. S., Kim, K., Kim, M. K., Kong, E., Kim, D. S., Eo, J. S., Lee, J. H., Kang, D. Y., Lee, W. S., Lee, S. M., Do, Y. R. & 6 others, Ham, J. S., Kim, S. J., Kim, W. S., Choi, J. Y., Yang, D. H. & Kwak, J. Y., 2018 Dec 1, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2482-2483 2 p.

Research output: Contribution to journalComment/debate

Peripheral T-Cell Lymphoma
Molecular Imaging
Nuclear Medicine
Treatment Failure
Venous Thromboembolism
Pancreatic Neoplasms
Retrospective Studies
Drug Therapy
gemcitabine

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma

Kang, K. W., Lee, S. R., Kim, D. S., Yu, E. S., Sung, H. J., Kim, S. J., Choi, C. W., Park, Y. & Kim, B. S., 2018 Feb 1, In : PLoS One. 13, 2, e0192656.

Research output: Contribution to journalArticle

non-Hodgkin lymphoma
computed tomography
Non-Hodgkin's Lymphoma
Tomography
relapse